PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: New England Journal of Medicine: Vytorin/Zetia cancer increase should not be assumed to be a chance finding until further data are in.
screen2largeMM

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.
.

PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.

Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Please read the terms of use agreement and privacy policy for this blog carefully.

New England Journal of Medicine: Vytorin/Zetia cancer increase should not be assumed to be a chance finding until further data are in.

"The fact that the combined data from all three trials showed an increase in cancer mortality with ezetimibe [Zetia] should not be assumed to be a chance finding until further data are in. "

This bomb is delivered on NEJM's editorial page.

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home